Does Pemafibrate Lower Low-Density Lipoprotein-Cholesterol? [PDF]
Fujioka Y.
europepmc +1 more source
Effects of Pemafibrate on LDL-C and Related Lipid Markers in Patients with MASLD: A Sub-Analysis of the PEMA-FL Study. [PDF]
Tanigawa R +9 more
europepmc +1 more source
Craniofacial bone anomalies related to cholesterol synthesis defects. [PDF]
Iwaya C +4 more
europepmc +1 more source
A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol. [PDF]
Förster F +26 more
europepmc +1 more source
Multi-omics analyses reveal differences in intestinal flora composition and serum metabolites in Cherry Valley broiler ducks of different body weights. [PDF]
Wang H +9 more
europepmc +1 more source
Personalized metabolite biomarker predictions reveal heterogeneous characteristics of Parkinson's disease. [PDF]
Abdik E, Çakır T.
europepmc +1 more source
Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation. [PDF]
Maroto-Juanes A +6 more
europepmc +1 more source
Knockouts of CYP51A1, DHCR24, or SC5D from cholesterol synthesis reveal pathways modulated by sterol intermediates. [PDF]
Skubic C +9 more
europepmc +1 more source

